This Week in Lancet Oncology | GenomeWeb

This Week in Lancet Oncology

Premium

In Lancet Oncology this week, researchers in Belgium and the Netherlands examine the long-term cognitive and cardiac consequences of prenatal exposure to chemotherapy, in children 18 months and older. The team assessed 70 children whose mothers underwent chemotherapy while pregnant, and found that although neurocognitive outcomes were within normal parameters, cognitive development scores were lower for the children born preterm compared to children born full term.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.